Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human insulin receptor monoclonal antibody-fused iduronate 2-sulfatase

EU orphan designation number: EU/3/13/1198   
Active ingredient: Recombinant human insulin receptor monoclonal antibody-fused iduronate 2-sulfatase
Indication: Treatment of mucopolysaccharidosis type II (Hunter's syndrome)
Sponsor: Voisin Consulting S.A.R.L.
3 rue des Longs Prés, F-92100 Boulogne-Billancourt, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/11/2013 Centralised Orphan - Designation EMA/OD/091/13 (2013)8044 of 13/11/2013